Delivery of nucleic acid therapeutics for cancer immunotherapy

Cancer immunotherapy has shown great potential as witnessed by an increasing number of immuno-oncology drug approvals in the past few years. Meanwhile, the field of nucleic acid therapeutics has made significant advancement. Nucleic acid therapeutics, such as plasmids, antisense oligonucleotides (AS...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Shurong, Chen, Wenjie, Cole, Janet, Zhu, Guizhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320672/
https://www.ncbi.nlm.nih.gov/pubmed/34337382
http://dx.doi.org/10.1016/j.medidd.2020.100023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320672/
https://www.ncbi.nlm.nih.gov/pubmed/34337382
http://dx.doi.org/10.1016/j.medidd.2020.100023

Ejemplares similares